The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sorafenib treatment duration in desmoid tumors.
 
Philippos Apolinario Costa
No Relationships to Disclose
 
Irvin Yi
No Relationships to Disclose
 
Arshia Arora
No Relationships to Disclose
 
Nicole Janell Hardy
No Relationships to Disclose
 
Steven Bialick
No Relationships to Disclose
 
Andrea P. Espejo-Freire
No Relationships to Disclose
 
Emily E Jonczak
No Relationships to Disclose
 
Kelly Olino
Patents, Royalties, Other Intellectual Property - Patent pending for the use of mRNA vaccine for the treatment of virally associated cancers.
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo/Lilly; Deciphera; Epizyme
 
Jonathan C. Trent
Consulting or Advisory Role - AADi; Agios; Bayer; Blueprint Medicines; Boehringer Ingelheim; C4 Therapeutics; Cogent Medicine; Daiichi Sankyo; Deciphera; Epizyme; Foghorn Therapeutics; SERVIER
 
Hari Anant Deshpande
Employment - Yale Cancer Center
Honoraria - Blueprint Medicines; Daiichi Sankyo; Deciphera; Exelixis
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo; Deciphera; Exelixis
Research Funding - Deciphera; Eisai; SpringWorks Therapeutics
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera